Topical heparin as an effective and safe treatment for patients with capecitabine-induced hand-foot syndrome: results of a phase IIA trial supported by proteomic profiling of skin biopsies.
Analia Rodríguez-GarzottoLara Iglesias-DocampoC Vanesa Díaz-GarcíaIsabel RuppenPilar Ximénez-EmbúnCarlos GómezJ Luis Rodríguez-PeraltoJavier Ortiz de FrutosJose A Lopez-MartinCristina GrávalosHernán Cortés-FunesMaría Teresa Agulló-OrtuñoPublished in: Therapeutic advances in medical oncology (2022)
EudraCT 2009-018171-13.